Literature DB >> 165392

Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells.

H Wolf, H Zur Hausen, G Klein, V Becker, G Henle, W Henle.   

Abstract

Fourteen tumors of the nasopharyngeal region were analyzed for the presence of Epstein-Barr virus-specific DNA by DNA-cRNA hybridization. These data were compared to the histology of the respective tumors and the seroreactivity of the tumor-bearing patient against EBV-related antigens. With one exception, all tumor pieces containing nasopharyngeal carcinoma cells hybridized significantly with EBV-cRNA. Tumors of predominantly epithelial morphology annealed in the highest range. In situ-hybridization of freeze sections from a tumor containing almost equal amounts of tumor cells and lymphocytes revealed hybridizing DNA within nuclei of non-lymphoid cells. Although these data do not exclude the presence of EBV-DNA within lymphoid cells, they clearly demonstrate that in nasopharyngeal carcinomas the vast majority of EBV-specific DNA rests within non-lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165392     DOI: 10.1007/bf02120766

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  15 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Authors:  L J Old; E A Boyse; H F Oettgen; E D Harven; G Geering; B Williamson; P Clifford
Journal:  Proc Natl Acad Sci U S A       Date:  1966-12       Impact factor: 11.205

3.  Nasopharyngeal carcinoma. IV. Evolution of complement-fixing antibodies during the course of the disease.

Authors:  G De-Thé; R Sohier; J H Ho; R Freund
Journal:  Int J Cancer       Date:  1973-09-15       Impact factor: 7.396

4.  Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses.

Authors:  H zur Hausen; H Schulte-Holthausen; H Wolf; K Dörries; H Egger
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

5.  Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus.

Authors:  H zur Hausen; W Meinhof; W Scheiber; G W Bornkamm
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

Review 6.  Viruses in human carcinogenesis.

Authors:  R M McAllister
Journal:  Prog Med Virol       Date:  1973

7.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

8.  Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics.

Authors:  M Nonoyama; J S Pagano
Journal:  Nature       Date:  1973-03-02       Impact factor: 49.962

9.  Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space.

Authors:  A de Schryver; S Friberg; G Klein; W Henle; G Henle; G De-Thé; P Clifford; H C Ho
Journal:  Clin Exp Immunol       Date:  1969-11       Impact factor: 4.330

10.  Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.

Authors:  R Glaser; F Rapp
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

View more
  11 in total

1.  A study of Epstein Barr virus receptor activity in cell free extracts of human lymphoblastoid cells.

Authors:  M H Ng; S W Lui; K H Chan
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  The culture of epithelial cells from nasopharyngeal carcinoma biopsies.

Authors:  S C Kook; U Prasad
Journal:  In Vitro Cell Dev Biol       Date:  1986-11

3.  Persistence of Epstein-Barr virus in the parotid gland.

Authors:  H Wolf; M Haus; E Wilmes
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

Review 4.  The role of miRNAs and EBV BARTs in NPC.

Authors:  Aron R Marquitz; Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2011-12-10       Impact factor: 15.707

5.  Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma.

Authors:  C K Chan; N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

Review 6.  Epstein-Barr virus infection and nasopharyngeal carcinoma.

Authors:  Sai Wah Tsao; Chi Man Tsang; Kwok Wai Lo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

7.  Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).

Authors:  T Takimoto; M Kamide; R Umeda
Journal:  Arch Otorhinolaryngol       Date:  1984

8.  Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.

Authors:  H C Ho; M H Ng; H C Kwan; J C Chau
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

9.  Possible transformation of nasopharyngeal epithelial cells in culture with Epstein-Barr virus from B95-8 cells.

Authors:  D P Huang; H C Ho; M H Ng; M Lui
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

10.  Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.

Authors:  A K Saemundsen; H Albeck; J P Hansen; N H Nielsen; M Anvret; W Henle; G Henle; K A Thomsen; H K Kristensen; G Klein
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.